Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA,
Target Price
The average target price of 4553.T is 3521 and suggests 4% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell